We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$28.6B
AUM Growth
+$1.5B
Cap. Flow
+$262M
Cap. Flow %
0.92%
Top 10 Hldgs %
43.01%
Holding
291
New
10
Increased
102
Reduced
100
Closed
10

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$67.8M
2
MSFT icon
Microsoft
MSFT
+$65M
3
AAPL icon
Apple
AAPL
+$45M
4
AMZN icon
Amazon
AMZN
+$42.8M
5
PM icon
Philip Morris
PM
+$40.2M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$56.2M
2
META icon
Meta Platforms (Facebook)
META
+$38.9M
3
AXP icon
American Express
AXP
+$32.9M
4
MS icon
Morgan Stanley
MS
+$32.6M
5
PG icon
Procter & Gamble
PG
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 23.05%
2 Consumer Staples 18.27%
3 Financials 17.61%
4 Energy 12.56%
5 Healthcare 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
51
Walt Disney
DIS
$171B
$127M 0.45%
1,272,699
+17,929
+1% +$1.81M
BR icon
52
Broadridge
BR
$19.7B
$127M 0.44%
866,352
+253,880
+41% +$36.3M
META icon
53
Meta Platforms (Facebook)
META
$1.49T
$121M 0.42%
569,153
-228,234
-29% -$38.9M
DEO icon
54
Diageo
DEO
$48.9B
$117M 0.41%
648,008
+74,994
+13% +$13.2M
WMT icon
55
Walmart Inc
WMT
$876B
$107M 0.37%
2,168,361
-54,441
-2% -$2.58M
BRK.B icon
56
Berkshire Hathaway Class B
BRK.B
$1.11T
$102M 0.36%
331,204
-17,494
-5% -$5.39M
ZTS icon
57
Zoetis
ZTS
$31.8B
$99.6M 0.35%
598,578
+27,210
+5% +$4.46M
VRSK icon
58
Verisk Analytics
VRSK
$25B
$94.3M 0.33%
491,477
-1,110
-0.2% -$201K
EOG icon
59
EOG Resources
EOG
$76.5B
$90.9M 0.32%
793,177
+304,746
+62% +$36.9M
BX icon
60
Blackstone
BX
$110B
$75.4M 0.26%
858,087
+244,990
+40% +$21.6M
STT icon
61
State Street
STT
$51.2B
$73M 0.26%
964,048
-200,315
-17% -$16.9M
AZN icon
62
AstraZeneca
AZN
$244B
$71.7M 0.25%
516,264
+503,916
+4,081% +$67.8M
OTIS icon
63
Otis Worldwide
OTIS
$27.8B
$70.9M 0.25%
840,572
+17,586
+2% +$1.46M
LLY icon
64
Eli Lilly
LLY
$1.01T
$68.4M 0.24%
199,278
+54,326
+37% +$18.3M
KMI icon
65
Kinder Morgan
KMI
$69.8B
$64.6M 0.23%
3,691,346
+304,851
+9% +$5.42M
PSX icon
66
Phillips 66
PSX
$82B
$63.5M 0.22%
625,878
+44,985
+8% +$4.57M
AXP icon
67
American Express
AXP
$235B
$60.2M 0.21%
364,658
-198,574
-35% -$32.9M
KMPR icon
68
Kemper
KMPR
$1.7B
$54.8M 0.19%
1,003,089
– –
TDY icon
69
Teledyne Technologies
TDY
$31.5B
$54.7M 0.19%
122,303
+22,377
+22% +$9.48M
IT icon
70
Gartner
IT
$11.9B
$54.1M 0.19%
166,211
-1,460
-0.9% -$483K
LECO icon
71
Lincoln Electric
LECO
$15.1B
$43.3M 0.15%
256,200
+26,500
+12% +$4.37M
HD icon
72
Home Depot
HD
$346B
$43M 0.15%
145,817
+1,831
+1% +$561K
TGT icon
73
Target
TGT
$67.8B
$42.7M 0.15%
258,048
+7,823
+3% +$1.29M
CME icon
74
CME Group
CME
$94.8B
$36.1M 0.13%
188,558
+162,535
+625% +$29.4M
PFE icon
75
Pfizer
PFE
$146B
$33.9M 0.12%
830,730
+18,295
+2% +$790K
1 2
3
4 5

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2023 Portfolio in Review

As of Q1 2023, Fayez Sarofim & Co held 291 positions worth $28.6B, up 5.6% from $27.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2023 filing shows 10 new, 102 increased, 100 reduced and 10 closed positions. Its largest new stake was MSCI: 9,600 shares worth $5.37M. The largest sale was Johnson & Johnson, an estimated $56.2M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Consumer Staples and Financials.

  • Fayez Sarofim & Co's largest Q1 2023 buy was MSCI: 9,600 shares worth $5.37M.
  • Fayez Sarofim & Co added most to AstraZeneca in Q1 2023, an estimated $67.8M increase.
  • Fayez Sarofim & Co's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $56.2M.
  • Fayez Sarofim & Co fully exited Cohen & Steers in Q1 2023, selling an estimated $3.23M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $28.6B portfolio in Q1 2023.
  • Fayez Sarofim & Co opened 10 new positions and closed 10 in Q1 2023.
  • Fayez Sarofim & Co's portfolio value rose 5.6% quarter-over-quarter to $28.6B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2023, filed 11 May 2023.